Holen Sie sich die Stockscreener-App
8.25
2.25%
-0.19
Handel nachbörslich:
8.21
-0.04
-0.48%
Schlusskurs vom Vortag:
$8.44
Offen:
$8.64
24-Stunden-Volumen:
2.18M
Relative Volume:
1.37
Marktkapitalisierung:
$716.08M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-168.09M
KGV:
-3.8018
EPS:
-2.17
Netto-Cashflow:
$-138.01M
1W Leistung:
+0.73%
1M Leistung:
+14.74%
6M Leistung:
+13.48%
1J Leistung:
-60.86%
1-Tages-Spanne:
$8.16
$8.75
1-Wochen-Bereich:
$8.08
$8.75
52-Wochen-Spanne:
$5.41
$21.40
Kura Oncology Inc Stock (KURA) Company Profile
Firmenname
Kura Oncology Inc
Sektor
Branche
Telefon
(858) 500-8800
Adresse
12730 HIGH BLUFF DRIVE, SUITE 400, SAN DIEGO, CA
Vergleichen Sie KURA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KURA
Kura Oncology Inc
|
8.25 | 732.57M | 0 | -168.09M | -138.01M | -2.17 |
|
VRTX
Vertex Pharmaceuticals Inc
|
383.12 | 99.25B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
591.99 | 63.46B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.56 | 59.27B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
736.76 | 44.78B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
334.40 | 37.75B | 3.81B | -644.79M | -669.77M | -6.24 |
Kura Oncology Inc Stock (KURA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-04 | Eingeleitet | Guggenheim | Neutral |
| 2025-02-06 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-10-24 | Eingeleitet | UBS | Buy |
| 2024-10-14 | Herabstufung | Stifel | Buy → Hold |
| 2023-12-22 | Eingeleitet | Mizuho | Buy |
| 2023-08-11 | Eingeleitet | BofA Securities | Buy |
| 2023-07-27 | Eingeleitet | Scotiabank | Sector Perform |
| 2023-05-17 | Eingeleitet | BTIG Research | Buy |
| 2023-01-31 | Eingeleitet | Stifel | Buy |
| 2022-07-12 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-02-15 | Eingeleitet | Jefferies | Buy |
| 2021-05-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-04-26 | Fortgesetzt | Credit Suisse | Outperform |
| 2020-12-07 | Bestätigt | H.C. Wainwright | Buy |
| 2020-12-03 | Eingeleitet | Stifel | Buy |
| 2020-11-05 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-07-07 | Eingeleitet | Credit Suisse | Outperform |
| 2020-05-05 | Eingeleitet | Barclays | Overweight |
| 2019-07-18 | Eingeleitet | Deutsche Bank | Buy |
| 2018-11-09 | Eingeleitet | Piper Jaffray | Overweight |
| 2018-08-01 | Eingeleitet | H.C. Wainwright | Buy |
| 2016-10-13 | Fortgesetzt | Leerink Partners | Outperform |
| 2016-01-22 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2015-12-30 | Eingeleitet | Oppenheimer | Outperform |
| 2015-12-16 | Eingeleitet | Citigroup | Buy |
Alle ansehen
Kura Oncology Inc Aktie (KURA) Neueste Nachrichten
Will Kura Oncology Inc. price bounce be sustainable2025 Price Targets & AI Driven Stock Movement Reports - newser.com
330,421 Shares in Kura Oncology, Inc. $KURA Bought by Acadian Asset Management LLC - MarketBeat
Intraday pattern recognizer results for Kura Oncology Inc.Market Risk Report & Safe Entry Momentum Stock Tips - newser.com
Automated trading signals detected on Kura Oncology Inc.Weekly Gains Report & Risk Controlled Stock Pick Alerts - newser.com
Chart based exit strategy for Kura Oncology Inc.Weekly Trade Report & Low Drawdown Momentum Ideas - newser.com
Kura Oncology, Inc. $KURA Shares Sold by Goldman Sachs Group Inc. - MarketBeat
Is Kura Oncology Inc. still worth holding after the dipQuarterly Profit Report & Weekly Watchlist for Consistent Profits - newser.com
Kura Oncology Inc. stock prediction for this weekWeekly Stock Recap & Weekly Return Optimization Alerts - newser.com
Kura Oncology Transitioning To Commercial Stage: Why I Choose To Buy (NASDAQ:KURA) - Seeking Alpha
AQR Capital Management LLC Acquires 610,604 Shares of Kura Oncology, Inc. $KURA - MarketBeat
Will Kura Oncology Inc. bounce back from current supportQuarterly Market Review & Verified Technical Trade Signals - newser.com
What MACD signals say about Kura Oncology Inc.July 2025 PostEarnings & Weekly Watchlist for Hot Stocks - newser.com
Sentiment Watch: Can Kura Oncology Inc. disrupt its industryQuarterly Investment Review & Safe Investment Capital Preservation Plans - خودرو بانک
Historical volatility pattern of Kura Oncology Inc. visualized2025 Trade Ideas & Fast Entry Momentum Trade Alerts - newser.com
Aug Catalysts: Will Kura Oncology Inc. benefit from current market trendsWeekly Trend Report & Free Safe Capital Growth Stock Tips - khodrobank.com
Smart tools for monitoring Kura Oncology Inc.’s price actionJuly 2025 Summary & High Yield Equity Trading Tips - newser.com
Promising Developments in Kura Oncology’s FTI Programs Highlighted by Analyst Buy Rating - TipRanks
Is Kura Oncology Inc. stock reversal real or fake2025 Institutional Moves & Verified Swing Trading Watchlists - newser.com
Setup Watch: Can Kura Oncology Inc disrupt its industryJuly 2025 EndofMonth & Low Drawdown Investment Ideas - khodrobank.com
Death Cross: How liquid is FTAI Infrastructure Inc stockMarket Activity Summary & Low Risk Entry Point Guides - خودرو بانک
Analysis Recap: Is Kura Oncology Inc benefiting from innovation trendsJuly 2025 Price Swings & Accurate Entry/Exit Alerts - khodrobank.com
Kura Oncology to present preliminary data on cancer drug darlifarnib - Investing.com India
Kura Oncology (NASDAQ:KURA) Shares Down 4.1%Should You Sell? - MarketBeat
Applying chart zones and confluence areas to Kura Oncology Inc.2025 Top Gainers & Weekly High Return Stock Forecasts - newser.com
Kura Oncology Highlights Preclinical Data Demonstrating Potential of Farnesyl Transferase Inhibitors to Overcome Drug Resistance in Combination with Key Targeted Therapies Across Multiple Tumor Types - The Manila Times
Breakthrough Cancer Drug Resistance Solution: Kura's KO-2806 Shows Promise Across 200K+ US Patients - Stock Titan
AI Stocks: Whats the profit margin of Kura Oncology IncMarket Rally & AI Driven Stock Movement Reports - khodrobank.com
Valuation Update: Is Kura Oncology Inc. in a long term uptrendJuly 2025 Sentiment & Reliable Breakout Stock Forecasts - khodrobank.com
Jobs Data: Does Kura Oncology Inc. align with a passive investing strategyJuly 2025 Reactions & Long-Term Safe Investment Plans - khodrobank.com
Kura Oncology (NASDAQ:KURA) Shares Gap Up on Insider Buying Activity - MarketBeat
Kura Oncology (NASDAQ:KURA) CEO Troy Edward Wilson Buys 50,000 Shares - MarketBeat
Jacobs Levy Equity Management Inc. Boosts Holdings in Kura Oncology, Inc. $KURA - MarketBeat
Analysts Set Kura Oncology, Inc. (NASDAQ:KURA) PT at $24.10 - MarketBeat
Hedge Fund and Insider Trading News: Leon Cooperman, David Tepper, Warren Buffett, Citadel Investment Group, Elliott Investment Management, Kura Oncology Inc (KURA), Grindr Inc (GRND), and More - Insider Monkey
Biotech Stocks Rally After-Hours On Trial Updates, Insider Buys, And Conference Buzz - RTTNews
Ieq Capital LLC Buys New Shares in Kura Oncology, Inc. $KURA - MarketBeat
EcoR1 Capital LLC Reduces Position in Kura Oncology, Inc. $KURA - MarketBeat
Kura Oncology, Inc. $KURA Shares Bought by Graham Capital Management L.P. - MarketBeat
Kura Oncology at H.C. Wainwright: Strategic Pipeline Developments By Investing.com - Investing.com Canada
Kura Oncology Inc. Shows Early Signs of Technical StrengthWatch List & Fast Gain Stock Tips - beatles.ru
LifeSci Capital Maintains Buy Rating on Kura Oncology (KURA) - Insider Monkey
Finanzdaten der Kura Oncology Inc-Aktie (KURA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.43%
0.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):